Tag: pathology
Paige adds $5M from Goldman Sachs to double down on AI-based cancer therapies
Paige, the Sloan-Kettering spinout that has been building an artificial intelligence platform to improve cancer pathology and subsequently use those insights to develop better drug therapies, has raised an additional $5 million in funding to continue its work commercialising its platform and expanding its research reach, while also getting FDA…
Read More